Corticomotoneuronal function and hyperexcitability in acquired neuromyotonia

Brain

Volumn 133, Issue 9, 2010, Pages 2727-2733

  Vucic, Steve ^a,b   Cheah, Benjamin C ^b,c   Yiannikas, Con ^d   Vincent, Angela ^e   Kiernan, Matthew C ^b,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d Department of Microbiology and Infectious Diseases   (Australia)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

acquired neuromyotonia; amyotrophic lateral sclerosis; cortical excitability

Indexed keywords

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BRAIN DEPTH STIMULATION; CLINICAL FEATURE; EVOKED MUSCLE RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR NERVE; MYOKYMIA; NERVE EXCITABILITY; NERVE FUNCTION; PERIPHERAL NERVE; PRIORITY JOURNAL; ACTION POTENTIAL; BRAIN CORTEX; COMPLICATION; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; MIDDLE AGED; MOTONEURON; NERVE CONDUCTION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROBABILITY; PROCEDURES; REACTION TIME; TRANSCRANIAL MAGNETIC STIMULATION; VERY ELDERLY;

ACTION POTENTIALS; ADULT; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; CEREBRAL CORTEX; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; EVOKED POTENTIALS, MOTOR; FEMALE; HUMANS; ISAACS SYNDROME; MALE; MIDDLE AGED; MOTOR NEURONS; NEURAL CONDUCTION; PERIPHERAL NERVES; PROBABILITY; REACTION TIME; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 77956373714     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awq188     Document Type: Article

References (50)

1. Auger RG. AAEM minimonograph #44: diseases associated with excess motor unit activity. Muscle Nerve 1994; 17: 1250-1263
2. Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler & Other Motor Neuron Disord 2000; 1: 293-299
3. Cantello R, Gianelli M, Civardi C, Mutani R. Magnetic brain stimulation: the silent period after the motor evoked potential. Neurology 1992; 42: 1951-1959
4. De Carvalho M, Bentes C, Evangelista T, Luis ML. Fibrillation and sharp-waves: do we need them to diagnose ALS? Amyotrophic Lateral Sclerosis & Other Motor Neuron Disorders 1999; 1: 29-32.
5. De Carvalho M, Dengler R, Eisen A, England JD, Kaji R, Kimura J, et al. Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol 2008; 119: 497-503.
6. De Carvalho M, Miranda PC, Lourdes Sales Luis M, Ducla-Soares E. Neurophysiological features of fasciculation potentials evoked by tran-scranial magnetic stimulation in amyotrophic lateral sclerosis. J Neurol 2000; 247: 189-194
7. De Carvalho M, Swash M. Nerve conduction studies in amyotrophic lateral sclerosis. Muscle Nerve 2000; 23: 344-352
8. De Carvalho M, Swash M. Cramps, muscle pain, and fasciculations: not always benign? Neurology 2004; 63: 721-723
9. Deymeer F, Oge AE, Serdaroglu P, Yazici J, Ozdemir C, Baslo A. The use of botulinum toxin in localizing neuromyotonia to the terminal branches of the peripheral nerve. Muscle Nerve 1998; 21: 643-646
10. Eisen A, Pant B, Stewart H. Cortical excitability in amyotrophic lateral sclerosis: a clue to pathogenesis. Can J Neurol Sci 1993; 20: 11-16
11. Fisher RJ, Nakamura Y, Bestmann S, Rothwell JC, Bostock H. Two phases of intracortical inhibition revealed by transcranial magnetic threshold tracking. Exp Brain Res 2002; 143: 240-248
12. Gubbay SS, Kahana E, Zilber N, Cooper G, Pintov S, Leibowitz Y. Amyotrophic lateral sclerosis. A study of its presentation and prognosis. J Neurol 1985; 232: 295-300.
13. Hart IK, Maddison P, Newsom-Davis J, Vincent A, Mills KR. Phenotypic variants of autoimmune peripheral nerve hyperexcitability. Brain 2002; 125: 1887-1895
14. Hart IK, Waters C, Newsom-Davis J. Cerebrospinal fluid and serum from acquired neuromyotonia patients seropositive for anti-potassium channel antibodies label dentate nucleus neurons. Ann Neurol 1996; 40: 554-555
15. Hart IK, Waters C, Vincent A, Newland C, Beeson D, Pongs O, et al. Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia. Ann Neurol 1997; 41: 238-246
16. Hirota N, Eisen A, Weber M. Complex fasciculations and their origin in amyotrophic lateral sclerosis and Kennedy's disease. Muscle Nerve 2000; 23: 1872-1875
17. Hosokawa S, Shinoda H, Sakai T, Kato M, Kuroiwa Y. Electrophysiological study on limb myokymia in three women. J Neurol Neurosurg Psychiatry 1987; 50: 877-881
18. Irani PF, Purohit AV, Wadia NH. The syndrome of continuous muscle fiber activity. Evidence to suggest proximal neurogenic causation. Acta Neurol Scand 1977; 55: 273-288
19. Isaacs H. A syndrome of continuous muscle-fibre activity. J Neurol Neurosurg Psychiatry 1961; 24: 391-425
20. Kaji R, Kohara N, Kimura J. Fasciculations evoked by magnetic cortical stimulation in patients with amyotrophic lateral sclerosis. Neurology 1993; 43 (Suppl. 2): A257-8.
21. Kanai K, Kuwabara S, Misawa S, Tamura N, Ogawara K, Nakata M, et al. Altered axonal excitability properties in amyotrophic lateral sclerosis: impaired potassium channel function related to disease stage. Brain 2006; 129: 953-962
22. Kiernan MC, Hart IK, Bostock H. Excitability properties of motor axons in patients with spontaneous motor unit activity. J Neurol Neurosurg Psychiatry 2001; 70: 56-64. (Pubitemid 32096121)
23. Kleine BU, Stegeman DF, Schelhaas HJ, Zwarts MJ. Firing pattern of fasciculations in ALS: evidence for axonal and neuronal origin. Neurology 2008; 70: 353-359
24. Kleopa KA, Elman LB, Lang B, Vincent A, Scherer SS. Neuromyotonia and limbic encephalitis sera target mature Shaker-type K+ channels: subunit specificity correlates with clinical manifestations. Brain 2006; 129: 1570-1584
25. Lance JW, Burke D, Pollard J. Hyperexcitability of motor and sensory neurons in neuromyotonia. Ann Neurol 1979; 5: 523-532
26. Liguori R, Vincent A, Clover L, Avoni P, Plazzi G, Cortelli P, et al. Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels. Brain 2001; 124: 2417-2426
27. Lutschg J, Jerusalem F, Ludin HP, Vassella F, Mumenthaler M. The syndrome of 'continuous muscle fiber activity'. Arch Neurol 1978; 35: 198-205.
28. Maddison P, Newsom-Davis J, Mills KR. Strength-duration properties of peripheral nerve in acquired neuromyotonia. Muscle Nerve 1999; 22: 823-830
29. Magistris MR, Rosler KM, Truffert A, Myers JP. Transcranial stimulation excites virtually all motor neurons supplying the target muscle. A demonstration and a method improving the study of motor evoked potentials. Brain 1998; 121: 437-450
30. Medical Research Council. Aid to the examination of the peripheral nervous system. London: Her Majesty's Stationary Office; 1976.
31. Mills KR, Murray NM. Electrical stimulation over the human vertebral column: which neural elements are excited? Electroencephalogr Clin Neurophysiol 1986; 63: 582-589
32. Newsom-Davis J. Autoimmune neuromyotonia (Isaacs' syndrome): an antibody-mediated potassium channelopathy. Ann N Y Acad Sci 1997; 835: 111-119
33. Newsom-Davis J, Mills KR. Immunological associations of acquired neu-romyotonia (Isaacs' syndrome). Report of five cases and literature review. Brain 1993; 116: 453-469
34. Nwosu VK, Royer JA, Stickler DE. Voltage gated potassium channel antibodies in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2010; 11: 392-394
35. Oh SJ, Alapati A, Claussen GC, Vernino S. Myokymia, neuromyotonia, dermatomyositis, and voltage-gated K+ channel antibodies. Muscle Nerve 2003; 27: 757-760
36. Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med 2001; 344: 1688-1700
37. Shiga Y, Onodera H, Shimizu H, Kimura I, Ohnuma A, Itoyama Y. Two consecutive fasciculation potentials having different motor unit origins are an electromyographically pathognomonic finding of ALS. Electromyogr Clin Neurophysiol 2000; 40: 237-241
38. Vagg R, Mogyoros I, Kiernan MC, Burke D. Activity-dependent hyper-polarization of human motor axons produced by natural activity. J Physiol 1998; 507: 919-925
39. Vincent A, Buckley C, Schott JM, Baker I, Dewar BK, Detert N, et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 2004; 127: 701-712
40. Vucic S, Howells J, Trevillion L, Kiernan MC. Assessment of cortical excitability using threshold tracking techniques. Muscle Nerve 2006; 33: 477-486
41. Vucic S, Kiernan MC. Axonal excitability properties in amyotrophic lateral sclerosis. Clin Neurophysiol 2006a; 117: 1458-1466
42. Vucic S, Kiernan MC. Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease. Brain 2006b; 129: 2436-2446
43. Vucic S, Kiernan MC. Pathophysiological insights into motor axonal function in Kennedy's disease. Neurology 2007; 69: 1828-1835
44. Vucic S, Kiernan MC. Cortical excitability testing distinguishes Kennedy's disease from amyotrophic lateral sclerosis. Clin Neurophysiol 2008; 119: 1088-1096
45. Vucic S, Nicholson GA, Kiernan MC. Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis. Brain 2008; 131: 1540-1550
46. Vucic S, Nicholson GA, Kiernan MC. Cortical excitability in hereditary motor neuronopathy with pyramidal signs: comparison with ALS. J Neurol Neurosurg Psychiatry 2010; 81: 97-100.
47. Wallis WE, Plum F. Continuous fasciculations, myokymia and muscle contraction due to peripheral nerve disease. Trans Assoc Am Physicians 1969; 82: 286-292
48. Warmolts JR, Mendell JR. Neurotonia: impulse-induced repetitive discharges in motor nerves in peripheral neuropathy. Ann Neurol 1980; 7: 245-250
49. Weber M, Eisen A, Nakajima M. Corticomotoneuronal activity in ALS: changes in the peristimulus time histogram over time. Clin Neurophysiol 2000; 111: 169-177
50. Zanette G, Tamburin S, Manganotti P, Refatti N, Forgione A, Rizzuto N. Different mechanisms contribute to motor cortex hyperexcitability in amyotrophic lateral sclerosis. Clin Neurophysiol 2002; 113: 1688-1697 (Pubitemid 35335457)